Dermatology NewsCamp Discovery: A place for children to be comfortable in their own skinJuly 14, 2023PediatricsRare DiseasesAtopic DermatitisPigmentation Disorders
Dermatology NewsNew guidelines for MTX use in pediatric inflammatory skin disease unveiledJuly 5, 2023PediatricsPsoriasisHair & NailsAtopic DermatitisRare Diseases
Dermatology NewsFDA approves ritlecitinib for ages 12 and up for alopecia areataJune 26, 2023Hair & NailsPediatricsAutoimmune DiseasesRare Diseases
Dermatology NewsDrugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Practice ManagementMelanomaNonmelanoma Skin CancerPediatricsBusiness of Medicine
Dermatology NewsAfter Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricingJune 16, 2023Business of MedicinePsoriatic ArthritisPediatricsPsoriasis
Dermatology NewsExperts share their sun protection tips for childrenJune 16, 2023MelanomaPediatricsNonmelanoma Skin Cancer
Dermatology NewsAdvising patients on AD treatment options: Expert pearlsJune 12, 2023Atopic DermatitisPediatrics
Extensive Erosions and Ulcerations on the Trunk and Extremities in a NeonateJune 5, 2023DermatopathologyPediatrics
Dermatology NewsDupilumab outcomes stable at end of open label atopic dermatitis studyJune 5, 2023Atopic DermatitisPediatrics
Dermatology NewsSPF is only the start when recommending sunscreensJune 2, 2023Pigmentation DisordersMixed TopicsNonmelanoma Skin CancerMelanomaPediatricsMelasma
Dermatology NewsJAK-inhibitor safety in adolescents with AD: Long-term analyses reportedMay 30, 2023Atopic DermatitisPediatrics
Dermatology NewsFDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
Dermatology NewsFDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023PediatricsPsoriatic ArthritisRare DiseasesPsoriasis
